company background image
524824

Bal Pharma BSE:524824 Stock Report

Last Price

₹83.65

Market Cap

₹1.3b

7D

-4.0%

1Y

-34.0%

Updated

31 Jan, 2023

Data

Company Financials

524824 Stock Overview

Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally.

524824 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health3/6
Dividends3/6

My Notes

New

Notes are coming soon

Bal Pharma Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bal Pharma
Historical stock prices
Current Share Price₹83.65
52 Week High₹139.00
52 Week Low₹82.50
Beta0.52
1 Month Change-8.28%
3 Month Change-8.38%
1 Year Change-33.98%
3 Year Change94.31%
5 Year Change-4.40%
Change since IPO728.22%

Recent News & Updates

Recent updates

Shareholder Returns

524824IN PharmaceuticalsIN Market
7D-4.0%-2.3%-4.4%
1Y-34.0%-5.4%-1.7%

Return vs Industry: 524824 underperformed the Indian Pharmaceuticals industry which returned -5.4% over the past year.

Return vs Market: 524824 underperformed the Indian Market which returned -1.7% over the past year.

Price Volatility

Is 524824's price volatile compared to industry and market?
524824 volatility
524824 Average Weekly Movement5.4%
Pharmaceuticals Industry Average Movement4.8%
Market Average Movement5.6%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market3.3%

Stable Share Price: 524824 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 524824's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1987837Shailesh Siroyahttps://www.balpharma.com

Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostrate enlargement, renal calculi, male infertility, women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; and cardiac care products under the Secremet and Servace brands.

Bal Pharma Limited Fundamentals Summary

How do Bal Pharma's earnings and revenue compare to its market cap?
524824 fundamental statistics
Market Cap₹1.31b
Earnings (TTM)₹42.72m
Revenue (TTM)₹2.80b

30.7x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
524824 income statement (TTM)
Revenue₹2.80b
Cost of Revenue₹1.63b
Gross Profit₹1.18b
Other Expenses₹1.13b
Earnings₹42.72m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Feb 06, 2023

Earnings per share (EPS)2.72
Gross Margin42.01%
Net Profit Margin1.52%
Debt/Equity Ratio177.2%

How did 524824 perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

26%

Payout Ratio